| Literature DB >> 26146516 |
Dimitrios Ioannou1, Lakshmi Kandukuri2, Joe Leigh Simpson1, Helen Ghislaine Tempest3.
Abstract
BACKGROUND: Genomes and by extension chromosome territories (CTs) in a variety of organisms exhibit nonrandom organization within interphase nuclei. CTs are susceptible to movement upon induction by a variety of stimuli, including: cell differentiation, growth factors, genotoxic agents, proliferating status, and stimulants that induce novel transcription profiles. These findings suggest nuclear architecture can undergo reorganization, providing support for a functional significance of CT organization. The effect of the initiation of transcription on global scale chromatin architecture has been underexplored. This study investigates the organization of all 24 human chromosomes in lymphocytes from two individuals in resting and phytohaemagglutinin activated lymphocytes using 2D and 3D approaches.Entities:
Keywords: Chromosome territories; Genome organization; Phytohaemagglutinin; Repositioning
Year: 2015 PMID: 26146516 PMCID: PMC4490598 DOI: 10.1186/s13039-015-0146-3
Source DB: PubMed Journal: Mol Cytogenet ISSN: 1755-8166 Impact factor: 2.009
Fig. 1Radial organization for all 24 CTs in resting and activated lymphocytes. Displays the radial distribution for all 24 CTs (chromosomes 1–22, X and Y) in both enrolled subjects for resting (-PHA) and activated (+PHA) lymphocytes. The X-axis for all histograms represents each of the five rings of equal area (1–5) moving from the nuclear interior toward the nuclear periphery (left to right). Each ring includes the data for the resting lymphocytes (dark blue and dark pink) and the activated lymphocytes (light blue and light pink) in the male and female subject, respectively. The Y-axis for all histograms represents the proportion of fluorescence (%) for each CT within each of the five rings. Error bars represent the standard error of the mean (SEM). Significant events of repositioning in activated lymphocytes compared to resting are denoted by letters (a–d) in the top right corner of each histogram, blue and pink letters correspond to repositioning events in the male and female subject, respectively. Each letter corresponds to the type or repositioning movement observed based on the radial distribution (see figure key for more details)
Random/nonrandom organization status of all 24 CTs in 2D resting and activated lymphocytes
| CT | Male | Female | Male | Female |
|---|---|---|---|---|
| -PHA | -PHA | +PHA | +PHA | |
| 1 | NR | NR | NR | NR |
| 2 | NR | NR | NR | |
| 3 | NR | |||
| 4 | NR | NR | NR | |
| 5 | NR | |||
| 6 | NR | NR | NR | NR |
| 7 | NR | NR | ||
| 8 | NR | NR | NR | NR |
| 9 | NR | NR | ||
| 10 | NR | NR | NR | NR |
| 11 | NR | NR | ||
| 12 | NR | NR | NR | NR |
| 13 | NR | |||
| 14 | NR | NR | NR | NR |
| 15 | NR | NR | NR | NR |
| 16 | NR | NR | NR | NR |
| 17 | NR | NR | NR | NR |
| 18 | NR | |||
| 19 | NR | NR | NR | NR |
| 20 | NR | NR | NR | NR |
| 21 | NR | NR | NR | NR |
| 22 | NR | NR | NR | NR |
| X | NR | NR | NR | NR |
| Y* | NR | - | - |
Presents the status (nonrandom or random) of CT organization for all chromosomes in resting (-PHA) and activated (+PHA) lymphocytes for each participant enrolled in this study. A minimum of 100 cells were captured and analyzed per CT, per subject in both resting (-PHA) and activated (+PHA) lymphocytes. The χ 2 goodness of fit test (d.f: 4) was utilized to determine whether the 2D radial distribution of each CT was random (p > 0.05) or nonrandom (p < 0.05). Nonrandom organization is denoted by NR (p < 0.05), random organization (p > 0.05) is denoted by blank boxes. *Data for the Y chromosome is only available from the male subject
Fig. 2Examples of 3D models demonstrating the various methods of analysis. A representative image of 3D models and measurements performed using Imaris (V.7.6.3) is provided for CT 17 (red) and CT 22 (green) in a resting (-PHA) and activated (+PHA) lymphocyte nucleus with a schematic representation shown below. Panels a-e, each show the same same nucleus and provides an example of each measurement performed. Panel a: diameter of the nucleus (-PHA 10.4 μm; +PHA 17.1 μm). Panel b: geometrical center of each CT, which is utilized by the distance transformation (DT) as the point to measure to the nearest nuclear edge in any direction (shown for CT 17 -PHA; and CT 22 + PHA). DT measurements for each nucleus are: CT 17: 1.84 μm, 3.29 μm and CT 22 3.43 μm, 3.97 μm (-PHA), CT 17 2.68 μm, 3.23 μm and CT 22 1.5 μm 1.93 μm (+PHA). Panel c: homologous CT measurements between the center of each CT (CT 17 5.34 μm, CT 22 2.44 μm -PHA; and CT 17 7.02 μm, CT 22 4.95 μm + PHA). Panel d: heterologous CT measurements between the center of the closet heterologous CT pair (CT 17–22 2.41 μm -PHA; and CT 17–22 4.58 μm + PHA) and the furthest heterologous CT pair (CT 17–22 2.41 μm -PHA; and CT 17–22 4.58 μm + PHA). Panel e: the same cell that has been rotated toward the left with 50 % of the DAPI plane removed “clipped” to better demonstrate the 3D aspect of the CTs within a 3D nucleus
Spatial relationship of CTs, nuclear diameter, and volume within 3D resting and activated lymphocytes
| CTs | PHA Status | Intraprobe left CT | Intraprobe right CT | Interprobe closest | Interprobe furthest | Nuclear diameter | Nuclear volume |
|---|---|---|---|---|---|---|---|
| μm | μm | μm | μm | μm | μm3 | ||
| 1 – 13 | -PHA | 4.21 (1.07) | 4.79 (1.28) | 3.52 (1.75) | 5.70 (2.0) | 10.27 (0.98) | 996.17 (278) |
| 1 – 13 | +PHA | 10.32 (2.53) | 8.82 (4.31) | 5.48 (2.26) | 9.59 (2.98) | 17.15 (2.4) | 2922.92 (1083) |
| 2 – 4 | -PHA | 5.83 (2.06) | 5.99 (1.66) | 3.72 (1.57) | 5.89 (1.87) | 10.54 (0.88) | 964.10 (137) |
| 2 – 4 | +PHA | 10.42 (3.29) | 8.99 (2.78) | 5.01 (2.19) | 9.76 (3.22) | 16.65 (2.07) | 3171.36 (1003) |
| 15 – 3 | -PHA | 4.49 (1.11) | 5.47 (1.95) | 2.80 (1.42) | 5.11 (1.87) | 10.45 (1.02) | 893.98 (236) |
| 15 – 3 | +PHA | 8.62 (2.7) | 8.71 (2.81) | 4.00 (2.2) | 8.48 (2.63) | 17.23 (2.21) | 3126.29 (1034) |
| 6 – 5 | -PHA | 4.89 (1.64) | 6.11 (2.03) | 2.86 (1.28) | 5.13 (1.59) | 10.49 (1.11) | 815.17 (238) |
| 6 – 5 | +PHA | 8.74 (3.23) | 9.48 (2.67) | 4.31 (2.32) | 8.80 (2.92) | 15.93 (1.95) | 2831.50 (849) |
| 8 – 7 | -PHA | 5.36 (1.81) | 5.99 (1.71) | 2.92 (1.18) | 5.49 (1.90) | 11.18 (1.10) | 971.98 (216) |
| 8 – 7 | +PHA | 7.73 (3.47) | 9.45 (2.84) | 4.91 (2.66) | 8.32 (2.58) | 15.10 (2.25) | 2422.48 (984) |
| 10 – 9 | -PHA | 5.08 (1.82) | 5.65 (2.03) | 3.47 (1.59) | 5.58 (1.78) | 11.12 (0.88) | 997.48 (227) |
| 10 – 9 | +PHA | 8.79 (2.75) | 7.48 (2.65) | 4.31 (2.15) | 7.99 (2.72) | 15.89 (1.99) | 2789.34 (936) |
| 12 – 11 | -PHA | 4.87 (1.39) | 5.17 (1.83) | 2.81 (1.34) | 5.05 (1.64) | 10.62 (1.06) | 806.81 (183) |
| 12 – 11 | +PHA | 7.24 (2.67) | 8.95 (3.14) | 3.51 (2.12) | 7.87 (3.39) | 16.04 (2.41) | 2628.15 (914) |
| 14 – 16 | -PHA | 4.58 (1.52) | 4.55 (1.62) | 3.00 (1.59) | 4.45 (1.48) | 10.48 (0.99) | 758.17 (181) |
| 14 – 16 | +PHA | 7.83 (3.03) | 7.86 (2.04) | 4.50 (2.36) | 8.29 (3.03) | 16.40 (2.16) | 2945.85 (1034) |
| 17 – 22 | -PHA | 4.25 (1.52) | 3.78 (1.29) | 2.85 (1.06) | 4.32 (1.66) | 10.54 (1.07) | 706.02 (173) |
| 17 – 22 | +PHA | 5.88 (1.73) | 4.81 (1.23) | 3.95 (1.41) | 6.41 (3.11) | 13.14 (1.85) | 2040.62 (757) |
| 19 – 18 | -PHA | 3.26 (1.34) | 5.38 (2.44) | 3.40 (1.31) | 5.36 (1.53) | 10.48 (1.24) | 873.05 (295) |
| 19 – 18 | +PHA | 6.88 (1.71) | 8.63 (3.77) | 4.80 (2.66) | 8.75 (3.02) | 17.70 (2.3) | 3333.78 (1151) |
| 21 – 20 | -PHA | 3.60 (1.6) | 5.17 (2.33) | 2.39 (1.41) | 5.12 (2.07) | 10.98 (1.32) | 931.65 (361) |
| 21 – 20 | +PHA | 7.79 (3.2) | 9.26 (3.42) | 3.71 (2.03) | 8.05 (3.72) | 18.31 (2.61) | 3530.47 (1335) |
| X – Y | -PHA | - | - | 3.99 (1.72) | - | 10.51 (1.07) | 797.52 (224) |
| X – Y | +PHA | - | - | 8.75 (3.69) | - | 17.87 (1.84) | 4225.90 (972) |
| X | -PHA | 4.68 (1.83) | - | - | - | 10.67 (0.95) | 831.76 (197) |
| X | +PHA | 5.32 (2.19) | - | - | - | 10.76 (1.46) | 1292.68 (480) |
Provides an overview of all the 3D measurements obtained utilizing Imaris software (V7.6.3) for all 24 CTs in resting and activated lymphocytes. The CTs column indicates which CTs were probed together in the dual FISH experiment (e.g. 1 - 13 indicates chromosomes 1 and 13). PHA status indicates whether data is from resting (-PHA) or activated (+PHA) lymphocytes. The remaining columns present the average measurements in microns (μm or μm3) obtained from a minimum of 40 cells (20 per subject with the exception of the X–Y and X–X data, with 20 cells from the male and female subject evaluated, respectively). Fig. 2 provides examples of how each distance was measured. The standard deviation of the measurements in all studied cells is provided in parentheses. The intraprobe columns provides the measurement between homologous CTs, the first intraprobe column provides the distance between the first CT listed in the CT column (e.g. CT 1), with the second intraprobe column providing the distance between the homologous CT pair for the second CT in the CT column (e.g. CT 13). The two interprobe columns provides the distances between the two heterologous CTs (e.g. CT 1 and CT 13), the first interprobe column presents the distance for the two closest CTs, with the second column presenting the data for the two furthest CTs. Subsequently, both the nuclear diameter and volume is provided
Comparison of radial hierarchical organization of CTs between 2D and 3D methods
| CT hierarchy -PHA 2D (median) | CT hierarchy -PHA 3D (distance) | CT hierarchy + PHA 2D (median) | CT hierarchy + PHA 3D (distance) | |
|---|---|---|---|---|
| Nuclear Interior | 19 (1.78) | 19 (0.61) | 22 (1.99) | 22 (0.52) |
| 17 (1.85) | 22 (0.57) | 17 (2.00) | 19 (0.51) | |
| 22 (1.85) | 1 (0.50) | 19 (2.06) | 21 (0.48) | |
| 1 (2.08) | 15 (0.49) | 21 (2.14) | 17 (0.46) | |
| 21 (2.10) | 17 (0.49) | 10 (2.27) | 16 (0.42) | |
| 16 (2.12) | 16 (0.48) | 15 (2.29) | 1 (0.41) | |
| 15 (2.17) | 21 (0.46) | 8 (2.31) | 12 (0.41) | |
| 9 (2.23) | 20 (0.45) | 14 (2.34) | 15 (0.40) | |
| 14 (2.25) | 12 (0.44) | 16 (2.34) | 8 (0.40) | |
| 20 (2.30) | 14 (0.43) | 12 (2.37) | 10 (0.39) | |
| 8 (2.33) | X (0.43) | 6 (2.49) | 7 (0.39) | |
| 6 (2.34) | 8 (0.42) | X (2.53) | 20 (0.39) | |
| 12 (2.34) | 6 (0.42) | 1 (2.54) | 14 (0.39) | |
| 10 (2.38) | 11 (0.40) | 20 (2.63) | 6 (0.38) | |
| X (2.42) | 10 (0.40) | 4 (2.76) | 9 (0.38) | |
| 11 (2.49) | 9 (0.39) | 5 (2.85) | Y* (0.36) | |
| 4 (2.53) | 2 (0.37) | 9 (2.89) | 18 (0.35) | |
| 7 (2.58) | Y* (0.37) | 2 (2.96) | X (0.34) | |
| 5 (2.62) | 4 (0.37) | 11 (2.96) | 3 (0.34) | |
| 2 (2.69) | 7 (0.37) | Y* (2.98) | 13 (0.33) | |
| 13 (2.73) | 13 (0.34) | 3 (3.04) | 5 (0.33) | |
| 3 (2.77) | 3 (0.34) | 18 (3.04) | 4 (0.32) | |
| 18 (2.77) | 18 (0.32) | 13 (3.05) | 2 (0.32) | |
| Nuclear Periphery | Y* (2.83) | 5 (0.32) | 7 (3.12) | 11 (0.31) |
Presents the radial hierarchy for all 24 CTs in resting and activated lymphocytes using both 2D and 3D approaches from both subjects. CTs are ordered from the nuclear interior (top of the table) toward the nuclear periphery (bottom of the table). Following the CTs in parentheses are the numerical values used to order the CTs. In the 2D approach, CTs are ordered based on the midpoint of the distribution of the CT fluorescence across the five rings of equal area (median) (200 cells/CT). In the 3D approach, CTs are ordered based on their (distance) to the nearest nuclear edge following normalization against the radius of the nucleus to account for differences in nucleus size (40 cells/CT). Data for CT Y (Y*) is obtained from the male subject only (2D: 100 cells; 3D: 20 cells)
CTs exhibiting radial repositioning in activated lymphocytes compared to resting lymphocytes
| 2D repositioning | |||
| Male Subject | Female Subject | ||
| CTs | Movement | CTs | Movement |
| 1, 6, 14, 16, 20 | Less interior | 1, 15, 19 | Less interior |
| 4, 5, 9 | Interior to intermediate | 11 | Interior to intermediate |
| 2 | Intermediate to periphery | 7 | Interior to periphery |
| X | Intermediate to interior | - | - |
| 3D repositioning | |||
| Male Subject | Female Subject | ||
| CTs | Movement | CTs | Movement |
| 11, 14, 15, 16, 17, 19 | More peripheral | 11, 16, 19, X | More peripheral |
CTs involved in statistical significant radial repositioning between resting and activated lymphocytes in both the male and female subject, as determined by 2D and 3D approaches. 2D radial repositioning was determined using the χ 2 goodness-of-fit test (p < 0.05). The direction of the repositioning movement was determined by comparing the radial distribution of CTs in each subject in resting and activated lymphocytes (Fig. 1). 3D radial repositioning was determined using the two-tailed, paired t-test (p < 0.05). The direction of the repositioning movement was determined based on the distance to the nuclear edge in activated lymphocytes compared to resting lymphocytes